Sort by
Refine Your Search
-
Category
-
Employer
- ICN2
- Institute of Photonic Sciences
- Josep Carreras Leukaemia Research Institute (IJC)
- Universitat de Barcelona
- BIODONOSTIA HEALTH RESEARCH INSTITUTE
- FUNDACIO INSTITUT D'INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- IRTA
- UNIVERSIDAD POLITECNICA DE MADRID
- Universitat Politècnica de Catalunya
- Universitat Politècnica de València
- 1 more »
- « less
-
Field
-
with a focus on III-V CQDs The aim of the project is to optimize the material properties as well as the device stack on a die level followed by integration of the optimum QD stack on a full image sensor
-
interactions of individual cell types. The candidate will be responsible for optimizing and implementing a tri-culture system containing iPSC-derived neurons, astrocytes and microglia cells and their
-
photoelectrode fabrication, producing novel ternary chalcogenide-based semiconductors with optimized band structures for efficient light-to-fuel conversion. The candidate will integrate selected electron transport
-
and to lead variety testing networks, to optimize agronomic practices and to be involved in knowledge transfer to farmers and related industry. A strong connection to the private sector, including local
-
, primarily light sheet fluorescence microscopy (LSFM) -Correlative 3D imaging of tissue structure and biology combining LSFM with high resolution X-ray computed tomography -Optimize sample preparation
-
, professional development, and mobility opportunities. The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and
-
, professional development, and mobility opportunities. The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and
-
FUNDACIO INSTITUT D'INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL | Spain | 2 months ago
of precision medicine aspects in Spain for the benefit of patients with Myotonic Dystrophy type 1 (DM1), prioritizing better diagnosis and optimization in the use of soon-to-be-available treatments. The DM1-Hub
-
interface between ESM and the latest version of SIESTA, its validation, its benchmarking, and its exploitation in scientific applications. Work will also involve the optimization of SIESTA on the fastest and